We are live on ! Find out more
CKPT

Checkpoint Therapeutics
CKPT

Delisted

CKPT was delisted on the 29th of May, 2025.

Back to rankings

62 hedge funds and large institutions have $33.4M invested in Checkpoint Therapeutics in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more call options, than puts

Call options by funds: $782K | Put options by funds: $304K

7% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 15

0% more ownership

Funds ownership: 1.4% → 1.4% (+0%)

4% less capital invested

Capital invested by funds: $34.7M → $33.4M (-$1.29M)

7% less funds holding

Funds holding: 67 → 62 (-5)

14% less first-time investments, than exits

New positions opened: 12 | Existing positions closed: 14

Holders
62
Holders Change
-5
Holders Change %
-7.46%
% of All Funds
0.95%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
16
Reduced
15
Closed
14
Calls
$782K
Puts
$304K
Net Calls
+$478K
Net Calls Change
-$121K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.59M
2
Norges Bank
Norges Bank
Norway
+$889K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$823K
4
Renaissance Technologies
Renaissance Technologies
New York
+$750K
5
Bank of America
Bank of America
North Carolina
+$682K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$989K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$506K
3
Marshall Wace
Marshall Wace
United Kingdom
-$402K
4
AMC
Asset Management Corp
Illinois
-$283K
5
Citadel Advisors
Citadel Advisors
Florida
-$270K
Name Holding Trade Value Shares
Change 		Change in
Stake
TI
26
Telemetry Investments
New York
$202K -$16.6K -500 -7%
Morgan Stanley
27
Morgan Stanley
New York
$190K -$189K -5,702 -48%
PAS
28
Park Avenue Securities
New York
$168K – – –
BC
29
Bartlett & Co
Ohio
$156K +$166K +5,000 New
BCWM
30
Bartlett & Co Wealth Management
Ohio
$156K +$166K +5,000 New
Qube Research & Technologies (QRT)
31
Qube Research & Technologies (QRT)
United Kingdom
$135K +$144K +4,344 New
Bank of New York Mellon
32
Bank of New York Mellon
New York
$132K – – –
Nisa Investment Advisors
33
Nisa Investment Advisors
Missouri
$127K – – –
Charles Schwab
34
Charles Schwab
California
$105K – – –
ED
35
Exane Derivatives
France
$97.2K -$56.2K -1,697 -35%
RJFSA
36
Raymond James Financial Services Advisors
Florida
$96K +$6.62K +200 +7%
OAM
37
Occidental Asset Management
California
$82K – – –
ECM
38
ExodusPoint Capital Management
New York
$80K +$27.6K +835 +48%
UBS Group
39
UBS Group
Switzerland
$77K -$37.4K -1,129 -31%
JF
40
Jump Financial
Illinois
$73K +$77.4K +2,338 New
MFS
41
Mirabella Financial Services
United Kingdom
$67K +$71.9K +2,170 New
TC
42
Tatro Capital
Kentucky
$59K +$1.52K +46 +3%
FAIM
43
Financial Advocates Investment Management
Washington
$47K – – –
SBH
44
Segall Bryant & Hamill
Illinois
$47K – – –
Truist Financial
45
Truist Financial
North Carolina
$43K -$695 -21 -1%
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
$43K – – –
JP Morgan Chase
47
JP Morgan Chase
New York
$43K +$46.2K +1,396 +69,800%
GSEP
48
Golden State Equity Partners
California
$41K +$43.4K +1,310 New
CI
49
Cordant Inc
Oregon
$34K – – –
TWM
50
Tradition Wealth Management
Minnesota
$32K +$4.97K +150 +17%
1
2
3 4

CKPT Hedge Fund Activity: Q4 2021 in Review

62 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q4 2021, worth a combined $33.4M — down 3.7% from $34.7M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CKPT and 12 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 16 added.

The largest buyer was Susquehanna International Group, adding an estimated $1.59M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $989K sold.

  • 62 institutional investors held Checkpoint Therapeutics (CKPT) as of Q4 2021, down from 67 in Q3 2021.
  • Funds reported $33.4M of Checkpoint Therapeutics stock for Q4 2021, down 3.7% quarter-over-quarter.
  • 12 funds opened new Checkpoint Therapeutics positions in Q4 2021 and 14 closed out, a net change of -2 holders.
  • The largest Checkpoint Therapeutics buyer in Q4 2021 was Susquehanna International Group, an estimated $1.59M added.
  • The largest Checkpoint Therapeutics seller in Q4 2021 was Two Sigma Investments, an estimated $989K sold.

Based on aggregated 13F filings for Q4 2021.